![Mark Hahn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Hahn
Director/Miembro de la Junta en
ALSP ORCHID ACQUISITION CORPORATION I
.
Perfil
Mark W.
Hahn is an Independent Director at ALSP Orchid Acquisition Corp.
I since 2021.
Mr. Hahn is a Director at Opterion Health AG.
Former roles include Independent Director at Soleno Therapeutics, Inc. from 2025 to 2026; Chief Financial Officer at Charles & Colvard Ltd. from 1984 to 1996; Chief Financial Officer, Secretary & Treasurer at Verona Pharma Ltd.; Chief Financial Officer at Equitel, Inc.; Principal at Ernst & Young LLP; Chief Financial Officer at Athenix Corp.
from 2008 to 2009; Chief Financial Officer & VP-Administration at Gigabeam Corp.
from 2007 to 2008; Chief Financial Officer at BuildLinks, Inc. from 2002 to 2007; Chief Financial Officer & Executive Vice President at Cempra Pharmaceuticals, Inc. and Cempra, Inc. from 2010 to 2017; Chief Financial Officer at Performaworks, Inc.; and Chief Financial Officer at Dova Pharmaceuticals, Inc. from 2018 to 2019.
Education includes an undergraduate degree from the University of Wisconsin-Milwaukee conferred in 1984.
Cargos activos de Mark Hahn
| Empresas | Cargo | Inicio |
|---|---|---|
| ALSP ORCHID ACQUISITION CORPORATION I | Director/Miembro de la Junta | 01/11/2021 |
Opterion Health AG
 Opterion Health AG Medical/Nursing ServicesHealth Services Provides chronic kidney disease services | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Mark Hahn.
| Empresas | Cargo | Fin |
|---|---|---|
| SOLENO THERAPEUTICS, INC. | Director/Miembro de la Junta | 15/05/2026 |
| DOVA PHARMACEUTICALS, INC. | Director Financiero/CFO | 12/11/2019 |
Cempra Pharmaceuticals, Inc.
 Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops medicines for treating drug-resistant bacterial infections | Director Financiero/CFO | 30/11/2017 |
Cempra, Inc.
 Cempra, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company with interest in manufacturing pharmaceutical products | Director Financiero/CFO | 01/11/2017 |
Athenix Corp.
 Athenix Corp. Chemicals: AgriculturalProcess Industries Develops agricultural herbicide tolerance and insect control chemicals | Director Financiero/CFO | 01/01/2009 |
Formación de Mark Hahn.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
50
Relaciones de 1er grado
15
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 15 |
|---|---|
Charles & Colvard Ltd.
 Charles & Colvard Ltd. Other Consumer SpecialtiesConsumer Durables Manufactures, markets, distributes and sells moissanite jewels | Consumer Durables |
Equitel, Inc.
 Equitel, Inc. Specialty TelecommunicationsCommunications Provides prepaid local telephone and cellular phone service | Communications |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Athenix Corp.
Athenix Corp. Chemicals: AgriculturalProcess Industries Develops agricultural herbicide tolerance and insect control chemicals | Process Industries |
Gigabeam Corp.
 Gigabeam Corp. Wireless TelecommunicationsCommunications Provides wireless communication solutions | Communications |
BuildLinks, Inc.
 BuildLinks, Inc. Packaged SoftwareTechnology Services Develops construction management and scheduling software for home builders | Technology Services |
Cempra Pharmaceuticals, Inc.
Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops medicines for treating drug-resistant bacterial infections | Health Technology |
Soleno Therapeutics, Inc.
 Soleno Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes novel therapeutics for the treatment of rare diseases | Health Technology |
Cempra, Inc.
Cempra, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company with interest in manufacturing pharmaceutical products | Health Technology |
Performaworks, Inc.
 Performaworks, Inc. Packaged SoftwareTechnology Services Provides data processing services | Technology Services |
Verona Pharma Plc
 Verona Pharma Plc Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of allergic rhinitis and other chronic respiratory diseases | Health Technology |
University of Wisconsin-Milwaukee
 University of Wisconsin-Milwaukee Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dova Pharmaceuticals, Inc.
 Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs with disorder of low blood platelet count | Health Technology |
Opterion Health AG
Opterion Health AG Medical/Nursing ServicesHealth Services Provides chronic kidney disease services | Health Services |
ALSP Orchid Acquisition Corp. I
 ALSP Orchid Acquisition Corp. I Financial ConglomeratesFinance Operates as a blank check company | Finance |
- Bolsa de valores
- Insiders
- Mark Hahn
